Single-dose study in patients [Design Issues]

posted by dshah  – India, 2023-12-11 11:44 (915 d 22:08 ago) – Posting: # 23792
Views: 4,226

Hi Brus!

❝ When you need to perform the study in patients due to tolerability/safety reasons, How do you perform the washout period in patients? (Between periods and before period 1 to avoid pre-dose concentrations in both periods).


Generally the patient study is required to be performed for stabilized patient. How can treatment be discontinued in patient?

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
163 visitors (0 registered, 163 guests [including 37 identified bots]).
Forum time: 10:52 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5